Evidence map›Paper›PMID 23255806›Full record

ArticleJournal of virology2013

An intronic G run within HIV-1 intron 2 is critical for splicing regulation of vif mRNA.

Marek Widera, Steffen Erkelenz, Frank Hillebrand, Aikaterini Krikoni, Darius Widera, Wolfgang Kaisers, René Deenen, Michael Gombert, Rafael Dellen, Tanya Pfeiffer and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
1.3field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Production of HIV-1Frontiers in microbiology · 2017
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

Marek WideraInstitute for Virology, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
Steffen Erkelenz
Frank Hillebrand
Aikaterini Krikoni
Darius Widera
Wolfgang Kaisers
René Deenen
Michael Gombert
Rafael Dellen
Tanya Pfeiffer
Barbara Kaltschmidt
Carsten Münk
Valerie Bosch
Karl Köhrer
Heiner Schaal
Heinrich Heine University Düsseldorf · DEBielefeld University · DEGerman Cancer Research Center · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Within target T lymphocytes, human immunodeficiency virus type I (HIV-1) encounters the retroviral restriction factor APOBEC3G (apolipoprotein B mRNA-editing enzyme, catalytic polypeptide-like 3G; A3G), which is counteracted by the HIV-1 accessory protein Vif. Vif is encoded by intron-containing viral RNAs that are generated by splicing at 3' splice site (3'ss) A1 but lack splicing at 5'ss D2, which results in the retention of a large downstream intron. Hence, the extents of activation of 3'ss A1 and repression of D2, respectively, determine the levels of vif mRNA and thus the ability to evade A3G-mediated antiviral effects. The use of 3'ss A1 can be enhanced or repressed by splicing regulatory elements that control the recognition of downstream 5'ss D2. Here we show that an intronic G run (G(I2)-1) represses the use of a second 5'ss, termed D2b, that is embedded within intron 2 and, as determined by RNA deep-sequencing analysis, is normally inefficiently used. Mutations of G(I2)-1 and activation of D2b led to the generation of transcripts coding for Gp41 and Rev protein isoforms but primarily led to considerable upregulation of vif mRNA expression. We further demonstrate, however, that higher levels of Vif protein are actually detrimental to viral replication in A3G-expressing T cell lines but not in A3G-deficient cells. These observations suggest that an appropriate ratio of Vif-to-A3G protein levels is required for optimal virus replication and that part of Vif level regulation is effected by the novel G run identified here.

Indexed as

RNA SplicingAmino Acid SequenceAPOBEC-3G DeaminaseCell LineCytidine DeaminaseHEK293 CellsHeLa CellsHIV-1HIV Envelope Protein gp41HumansIntronsJurkat CellsMolecular Sequence DataMutationrev Gene Products, Human Immunodeficiency VirusRNA, MessengerAPOBEC-3G DeaminaseAPOBEC3G protein, humanCytidine DeaminaseHIV Envelope Protein gp41rev Gene Products, Human Immunodeficiency Virusrev protein, Human Immunodeficiency Virus-1RNA, MessengerRNA Splice SitesRNA, Viralvif Gene Products, Human Immunodeficiency Virus

Identifiers

PMID23255806
PMCPMC3571361
OpenAlexW1972538317

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.